M. Kneussl (Vienna, Austria), M. Bogdan (Bucharest, Romania), R. Bals (Homburg, Germany), M. Breyer (Vienna, Austria)
Inhibiting effects of tiotropium bromide on neocollagenesis during 6 month treatment
M. Ostrovskyy, O. Varunkiv, M. Kulynych-Miskiv, I. Savelikhina (Ivano-Frankivsk, Ukraine)
|   |
Effect of erdosteine on airflow obstruction and symptom recovery in severe COPD exacerbations
M. Moretti, M. Ballabio (Carrara, Milan, Italy)
| |
Analysis of therapy of community-acquired pneumonia (CAP) at the COPD patients
H. Demchuk, Y. Mostovoy (Vinnytsia, Ukraine)
| |
Perioperative pulmonary complications and management of patients with COPD and esophageal malignancy
Y. Yamakova, R. Petkov, G. Yankov, E. Astrukov, D. Petrov (Sofia, Bulgaria)
| |
Index of myocardial injury CIIS and mortality of patients with chronic obstructive pulmonary disease
N. Karoli, A. Rebrov (Saratov, Russian Federation)
| |
Polypharmacy in patients with acute exacerbation of COPD
J. Díez-Manglano, J. Barquero-Romero, P. Almagro-Mena, J. B. Soriano, J. Recio-Iglesias, F. J. Cabrera-Aguilar, ECCO Study Investigators (Zaragoza, Badajoz, Tarrasa, Barcelona, Madrid, Bunyola, Mallorca, Spain)
| |
Comparison of two models of factors associated to hospital admission for COPD
B. Alcázar Navarrete, A. Herrejón Silvestre, C. García Polo, L. A. Ruiz, P. García Sidro, G. Tirado Conde, J. A. Ros Lucas, C. Martínez Rivera, J. Costán, S. Mayoralas, M. Miravitlles, InEPOC Group (Jaen, Valencia, Cadiz, Baracaldo, Castellon de la Plana, Manresa, Murcia, Barcelona, Zaragoza, Madrid, Spain)
| |
More than two years of a monographic consultation on control of chronic home oxygen therapy
T. Bilbao Goyoaga, N. Quilez, L. Comeche, D. Alvaro, J. M. Diez, R. Perez (Mostoles, Spain)
| |
How we can modify the steroid insensitivity in patients with chronic obstructive pulmonary disease? The new pharmacological approach to old problem
A. Sadigov, J. Mammadov, G. Alieva (Baku, Azerbaijan)
| |
The influence of high doses of N-acetylcysteine alone or in combination with inhaled corticosteroids on quality of life in patients with COPD
V. Kapustina, S. Ovcharenko (Moscow, Russian Federation)
| |
Gender differences of predictors of health status in patients with COPD
M. Coliba, A. Corlateanu, V. Botnaru (Chisinau, Republic Of Moldova)
| |
The subclinical atherosclerosis and its association to clinical features of stable COPD
O. Salman Sever, I. Conkbayir, M. Yuce Ege, S. Akcali, H. Firat, T. Kaplan, S. Ardic (Ankara, Turkey)
| |
Prevalence of heart disease in patients hospitalized for an acute exacerbation of COPD: Impact on clinical outcome. A 6 month follow-up study
S. Fernandez Serrano, D. Sanchez Berenguer, J. Oriol, L. San Vicente, N. Galofre, G. Beltran, M. Altimira, L. Ortega (Badalona, Spain)
| |
COPD circle of care: Patient centred education and counselling tool for COPD self-management
C. Chan (Toronto, Canada)
| |
Influence of tiotropium bromide (TB) on the severity of clinical, functional symptoms and health-related quality of life (HRQL) in COPD patients (pts)
L. Konopkina, T. Pertseva, V. Berezovskyi, B. Basina (Dnipropetrovsk, Ukraine)
| |
The comparative characteristic of respiratory muscles function in patients with bronchial obstruction
T. Pertseva, O. Myronenko (Dnipropetrovsk, Ukraine)
| |
Comparative characteristics of protein metabolism disorders in patients with occupational and non-occupational COPD
S. Panina, N. Sanina, N. Gondulenko, T. Igumnova (Dnipropetrovsk, Ukraine)
| |
Evaluation of incontinence and quality of life in patiens with chronic obstructive pulmonary disease (COPD) and bronchiectasis
C. Brockwell, A. Clark, A. Baker, B. Hicken, G. Pardo, H. Little, A. Wilson (Norwich, United Kingdom)
| |
Initial clinical phenotype of COPD: Correlation with the natuaral history of the disease
L. Fasano, A. M. G. Pacilli, P. Carbonara, V. Di Scioscio, I. Valentini, G. Mistè, A. Montanari, M. Fabbri, M. Zompatori, S. Nava (Bologna, Italy)
| |